Cell kinetic study of normal human bone marrow hematopoiesis and acute leukemia using 7AAD/PY

European Journal of Haematology

Volumn 64, Issue 1, 2000, Pages 10-21

  Toba, Ken ^a   Koike, Tadashi ^a   Watanabe, Kenichi ^a   Fuse, Ichiro ^a   Takahashi, Masuhiro ^a   Hashimoto, Shigeo ^a   Takahashi, Hidenobu ^a   Abe, Takashi ^a   Yano, Toshio ^a   Shibazaki, Yasuhiko ^a   Itoh, Hiromi ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

7AAD PY; Acute leukemia; DNA RNA quantification; Flow cytometry; Normal hematopoiesis

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; DNA; RNA;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL CYCLE S PHASE; CELL KINETICS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RNA ANALYSIS;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW CELLS; CELL CYCLE; CELLS, CULTURED; DACTINOMYCIN; DNA; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; KINETICS; LEUKEMIA; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, T-CELL, ACUTE; MALE; RNA;

EID: 0033977978     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.09005.x     Document Type: Article

References (64)

1. 1. Drach J, Gattringer C, Glassl H, Schwarting R, Steinn H, Huber H. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma. Cytometry 1989;10:743-749.
2. 2. Kastan MB, Stone KD, Civin CI. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferalive status of normal human hemopoietic cells. Blood 1989;74:1517-1524.
3. 3. Lopez F, Belloc F, Lacombe F, et al. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 1991;12:42-49.
4. 4. Kurki P, Ogata K, Tan EM. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 1988;109:49-59.
5. 5. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983;80:5573-5577.
6. 6. Dolbeare F, Beisker W, Pallavicini MG, Vanderlaan M, Gray JW. Cytochemistry for bromodeoxyuridine/DNA analysis: Stoichiometry and sensitivity. Cytometry 1985; 6:521-530.
7. 7. Raza A, Maheshwari Y, Preisler HD. Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemia. Blood 1987;69:1647-1653.
8. 8. Toba K, Winton EF, Bray RA. Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation. Cytometry 1992;13:60-67.
9. 9. Darzynkiewicz Z, Traganos F, Melamed MR. New cell cycle compartments identified by multiparametric flow cytometry. Cytometry 1980;1:98-108.
10. 10. Darzynkiewicz Z, Sharpless T, Staiano-Coico L, Melamed MR. Subcompartments of the G1 phase of cell cycle detected by flow cytometry. Proc Natl Acad Sci USA 1980;77:6696-6699.
11. 11. Andreeff M, Darzynkiewicz Z, Sharpless TK, Clarkson B, Melamed MR. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 1980;55:282-293.
12. 12. Walker C, Kristensen F, Bettens F, DeWeck AL. Lymphokine regulation of activated (G1) lymphocytes; I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol 1983;130:1770-1773.
13. 13. Bettens F, Kristensen F, Walker C, Schwulera U, Bonnard GD, DeWeck AL. Lymphokine regulation of activated (G1) lymphocytes; II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation. J Immunol 1984;132:261-265.
14. 14. Toba K, Winton EF, Koike T, Shibata A. Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin-D and Pyronin Y. J Immunol Methods 1995;182:193-207.
15. 15. Toba K. Information on the cell cycle for diagnosis of lymphoma using 7AAD/PY. Jpn J Res 1995;35:51-58.
16. 16. Toba K. Combined analysis of DNA, RNA and an antigen. In: Ormerod MG, ed. Data Analysis in Flow Cytometry: A Dynamic Approach. London: Pheonix Flow Systems, 1996; chapt. 10.1.3.
17. 17. Winton EF, Bucur SZ, Bray RA, et al. The hematopoietic effects of recombinant human (rh) FLT3 ligand administered to non-human primates. Blood 1995;Suppl 1:424a.
18. 18. Ogata K, An E, Kamikubo K, et al. Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometry. Exp Hematol 1997;25:8-18.
19. 19. Toba K, Koike T, Takahashi M, et al. Characterization and sensitivity to interleukin 2 and interferon α of leukemic cells from a patient with large granular lymphocytic leukemia associated with chronic active Epstein Barr virus infection. Leuk Res 1997;21:941-950.
20. 20. Toba K, Koike T, Wang Y, et al. Prediction of growth sensitivity of acute promyelocytic leukemia cells to granulocyte colony-stimulating factor using 7AAD/PY during administration of all-trans retinoic acid. Int J Hematol 1997;66:203-212.
21. 21. Toba K, Kishi K, Koike T, et al. Profile of cell cycle in hematopoietic malignancy by DNA/RNA quantitation using 7AAD/PY. Exp Hematol 1996;24:894-901.
22. 22. Zelenin AV, Poletaev AI, Stepanova NG, et al. 7-amino-actinomycin D as a specific fluorophore for DNA content analysis by laser flow cytometry. Cytometry 1984;5: 348-354.
23. 23. Muller W, Crothers DM. Interactions of heteroaromatic compounds with nucleic acids; I. The influence of heteroatoms and polarizabilily on the base specificity on intercalating ligands. Eur J Biochem 1975;54:267-277.
24. 24. Holdrinet RSG, Egmond JV, Wessels JMC, Haanen C. A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol 1980;8:103-107.
25. 25. Mishell BB, Shiigi SM. Selected methods in cellular immunology. San Francisco: WH Freedman Co, 1980: 23-24.
26. + cord blood. Pediatr Res 1992;32:277-281.
27. 27. Law P, Ishizawa L, Van De Ven C, et al. Immunomagnetic positive selection and colony culture of CD34 cells from cord blood. J Hematother 1993;2:247-250.
28. 28. Miltenyi S, Muller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990;11:231-238.
29. 29. Bennett JM, Catowsky D, Danier MT, et al. Proposals for the classification of the acute leukemias. Br J Haematol 1976;33:451-458.
30. 30. Bennett JM, Catowsky D, Danier MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Ann Int Med 1985;103:460-462.
31. 31. Bennett JM, Catowsky D, Danier MT, et al. Proposal for the recognilion of minimally differenliated acute myeloid leukemia (AML-M0). Br J Haematol 1990;78:325-329.
32. 32. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995;9:1783-1786.
33. 33. Rothe G, Schmitz G, Adorf D, et al. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996;10:877-895.
34. 34. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.
35. 35. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 1997;90: 5013-5021.
36. 36. Barlogie B, Maddox AM, Johnston DA, et al. Quantitative cytology in leukemia research. Blood Cells 1983;1:35-55.
37. 37. Maddox AM, Johnston DA, Barlogie B, Youness E, Keating MJ, Freireich EJ. DNA RNA measurements in patients with acute leukemia undergoing remission induction therapy. J Clin Oncol 1985;3:799-808.
38. - progenitor cells. Blood 1991;77:1218-1227.
39. - hematopoietic stem cells. Blood 1994;83:1515-1526.
40. 40. Nimer SD, Paquette RL, Ireland P, Resta D, Young D, Golde DW. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol 1994;22:875-880.
41. 41. Lopez KD, Guinan EC. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia. Pediatr Nursing 1995;21:345-349.
42. 42. Cortelazzo S, Viero P, Bellavita P, et al. Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma. J Clin Oncol 1995;13:935-941.
43. 43. Haas R, Hohaus S, Goldschmidt H, et al. High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization. (Review) Semin Oncol 1994;21(6 Suppl 16):19-24.
44. 44. Hiddemann W, Wormann B, Reuter C, et al. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors. (Review) Semin Oncol 1994;21(6 Suppl 16):33-38.
45. 45. Richard C, Baro J, Bello-Fernandez C, et al. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. Bone Marrow Transplant 1995;15:721-726.
46. 46. Matsushime H, Ewen ME, Strom DK, et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/ cdk4) for mammalian D type G1 cyclins. Cell 1992;71: 323-334.
47. 47. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase Activity, is related to p21. Cell 1994;78:67-74.
48. 48. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211:90-98.
49. 49. Drexler HG, Gignac SM, Minowada J. Routine immunophenotyping of acute leukemias. Blut 1988;57:327-339.
50. 50. Bettelheim P, Paieita E, Majdic O, Gadner H, Schwarzmeier J, Knapp W. Expression of a myeloid marker on TdT-positive acute lymphocytic leukemic cells: evidence by double-fluorescence staining. Blood 1982;60: 1392-1396.
51. 51. Neame PB, Soamboonsrup P, Browman G, et al. Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. Blood 1985;65:142-148.
52. 52. Palumbo A, Minowada J, Erikson J, Croce CM, Rovera G. Lineage infidelity of a human myelogeneous leukemia cell line. Blood 1984;64:1059-1063.
53. 53. Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayer H, McCulloch EA. Lineage infidelity in acute leukemia. Blood 1983;61:1138-1145.
54. 54. Cline MJ. Review: The molecular basis of leukemia. N Engl J Med 1994;330:328-336.
55. 55. Copelan EA, McGuire EA. Review: Biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995;85: 1151-1168.
56. 56. Garand R, Duchayne E, Blanchard D, et al. Minimally differentiated erythroleukemia (AML M6 "variant"): a rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 1995;90:868-875.
57. 57. Nagai K, Kohno T, Chen YX, et al. Diagnostic criteria for hypocellular acute leukemia: A clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. Leuk Res 1996;20:563-574.
58. 58. Brito-Babapulle F, Catovsky D, Galton DA. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 1987;66:445-450.
59. 59. Koeffler HP, Ranyard J, Pertcheck M. Myeloperoxidase: Its structure and expression during myeloid differentiation. Blood 1985;65:484-491.
60. 60. Murao S, Stevens FJ, Ito A, Huberman E. Myeloperoxidase: A myeloid cell nuclear antigen with DNA-binding properties. Proc Natl Acad Sci USA 1988;85:1232-1236.
61. + normal human hemopoietic cells. Blood 1993;82:2069-2078.
62. 62. Campana D, Thompson JS, Amlot P, Brown S, Janossy G. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 1987;138:648-655.
63. 63. Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 1989;3:170-181.
64. 64. Garand R, Voisin S, Papin S, et al. Characteristics of pro-T ALL subgroups: Comparison with late T-ALL. Leukemia 1993;7:161-167.